New Nordic Healthbrands AB (publ) (NNH) - Net Assets
Based on the latest financial reports, New Nordic Healthbrands AB (publ) (NNH) has net assets worth Skr101.97 Million SEK (≈ $10.97 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr264.32 Million ≈ $28.45 Million USD) and total liabilities (Skr162.35 Million ≈ $17.47 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore New Nordic Healthbrands AB (publ) (NNH) total assets for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr101.97 Million |
| % of Total Assets | 38.58% |
| Annual Growth Rate | 15.4% |
| 5-Year Change | -14.01% |
| 10-Year Change | 140.73% |
| Growth Volatility | 30.55 |
New Nordic Healthbrands AB (publ) - Net Assets Trend (2008–2025)
This chart illustrates how New Nordic Healthbrands AB (publ)'s net assets have evolved over time, based on quarterly financial data. Check NNH tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for New Nordic Healthbrands AB (publ) (2008–2025)
The table below shows the annual net assets of New Nordic Healthbrands AB (publ) from 2008 to 2025. For live valuation and market cap data, see market cap of New Nordic Healthbrands AB (publ).
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | Skr103.47 Million ≈ $11.13 Million |
+2.92% |
| 2024-12-31 | Skr100.53 Million ≈ $10.82 Million |
-5.19% |
| 2023-12-31 | Skr106.03 Million ≈ $11.41 Million |
-5.81% |
| 2022-12-31 | Skr112.57 Million ≈ $12.11 Million |
-6.44% |
| 2021-12-31 | Skr120.32 Million ≈ $12.95 Million |
+14.80% |
| 2020-12-31 | Skr104.81 Million ≈ $11.28 Million |
+2.84% |
| 2019-12-31 | Skr101.92 Million ≈ $10.97 Million |
+27.06% |
| 2018-12-31 | Skr80.21 Million ≈ $8.63 Million |
+31.91% |
| 2017-12-31 | Skr60.81 Million ≈ $6.54 Million |
+41.49% |
| 2016-12-31 | Skr42.98 Million ≈ $4.63 Million |
+20.15% |
| 2015-12-31 | Skr35.77 Million ≈ $3.85 Million |
+42.75% |
| 2014-12-31 | Skr25.06 Million ≈ $2.70 Million |
+84.95% |
| 2013-12-31 | Skr13.55 Million ≈ $1.46 Million |
+59.93% |
| 2012-12-31 | Skr8.47 Million ≈ $911.72K |
-27.15% |
| 2011-12-31 | Skr11.63 Million ≈ $1.25 Million |
+1.76% |
| 2010-12-31 | Skr11.43 Million ≈ $1.23 Million |
-22.87% |
| 2009-12-31 | Skr14.82 Million ≈ $1.59 Million |
+63.43% |
| 2008-12-31 | Skr9.07 Million ≈ $975.75K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to New Nordic Healthbrands AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 1439100000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | Skr6.20 Million | 5.99% |
| Other Comprehensive Income | Skr-68.00K | -0.07% |
| Other Components | Skr97.34 Million | 94.08% |
| Total Equity | Skr103.47 Million | 100.00% |
New Nordic Healthbrands AB (publ) Competitors by Market Cap
The table below lists competitors of New Nordic Healthbrands AB (publ) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Arcoma AB
ST:ARCOMA
|
$12.93 Million |
|
Kainos Group PLC
LSE:KNOS
|
$12.94 Million |
|
Thunderful Group AB
ST:THUNDR
|
$12.95 Million |
|
Tempest Therapeutics Inc
NASDAQ:TPST
|
$12.96 Million |
|
Flour Mills Kepenos S.A.
AT:KEPEN
|
$12.93 Million |
|
FingerMotion Inc
NASDAQ:FNGR
|
$12.93 Million |
|
DB (International) Stock Brokers Limited
NSE:DBSTOCKBRO
|
$12.93 Million |
|
Cadrenal Therapeutics, Inc. Common Stock
NASDAQ:CVKD
|
$12.93 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in New Nordic Healthbrands AB (publ)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 100,915,000 to 103,465,000, a change of 2,550,000 (2.5%).
- Net income of 8,195,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 5,644,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr8.20 Million | +7.92% |
| Other Comprehensive Income | Skr-5.64 Million | -5.45% |
| Other Changes | Skr-1.00K | -0.0% |
| Total Change | Skr- | 2.53% |
Book Value vs Market Value Analysis
This analysis compares New Nordic Healthbrands AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.16x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 13.26x to 1.16x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2008-12-31 | Skr1.46 | Skr19.40 | x |
| 2009-12-31 | Skr2.39 | Skr19.40 | x |
| 2010-12-31 | Skr1.84 | Skr19.40 | x |
| 2011-12-31 | Skr1.88 | Skr19.40 | x |
| 2012-12-31 | Skr1.37 | Skr19.40 | x |
| 2013-12-31 | Skr2.19 | Skr19.40 | x |
| 2014-12-31 | Skr4.04 | Skr19.40 | x |
| 2015-12-31 | Skr5.77 | Skr19.40 | x |
| 2016-12-31 | Skr6.94 | Skr19.40 | x |
| 2017-12-31 | Skr9.82 | Skr19.40 | x |
| 2018-12-31 | Skr12.95 | Skr19.40 | x |
| 2019-12-31 | Skr16.45 | Skr19.40 | x |
| 2020-12-31 | Skr16.92 | Skr19.40 | x |
| 2021-12-31 | Skr19.42 | Skr19.40 | x |
| 2022-12-31 | Skr18.17 | Skr19.40 | x |
| 2023-12-31 | Skr17.12 | Skr19.40 | x |
| 2024-12-31 | Skr16.29 | Skr19.40 | x |
| 2025-12-31 | Skr16.70 | Skr19.40 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently New Nordic Healthbrands AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 7.92%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 1.42%
- • Asset Turnover: 2.34x
- • Equity Multiplier: 2.38x
- Recent ROE (7.92%) is above the historical average (1.03%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2008 | -158.72% | -7.15% | 1.53x | 14.53x | Skr-15.30 Million |
| 2009 | 6.30% | 0.41% | 1.81x | 8.43x | Skr-547.80K |
| 2010 | -50.13% | -2.93% | 1.90x | 9.00x | Skr-6.87 Million |
| 2011 | 2.67% | 0.16% | 2.11x | 8.13x | Skr-852.00K |
| 2012 | -48.23% | -2.01% | 2.22x | 10.83x | Skr-4.93 Million |
| 2013 | 42.67% | 2.54% | 2.53x | 6.66x | Skr4.43 Million |
| 2014 | 49.38% | 4.55% | 2.70x | 4.02x | Skr9.87 Million |
| 2015 | 31.67% | 3.80% | 2.38x | 3.50x | Skr7.75 Million |
| 2016 | 22.28% | 3.13% | 2.40x | 2.97x | Skr5.28 Million |
| 2017 | 33.38% | 5.89% | 2.48x | 2.28x | Skr14.22 Million |
| 2018 | 33.07% | 6.74% | 2.42x | 2.03x | Skr18.50 Million |
| 2019 | 27.55% | 6.20% | 2.30x | 1.93x | Skr17.88 Million |
| 2020 | 16.95% | 3.95% | 2.35x | 1.83x | Skr7.28 Million |
| 2021 | 17.71% | 4.14% | 2.16x | 1.98x | Skr9.27 Million |
| 2022 | -2.51% | -0.58% | 1.94x | 2.24x | Skr-14.08 Million |
| 2023 | -5.84% | -1.16% | 2.14x | 2.35x | Skr-16.80 Million |
| 2024 | -7.63% | -1.40% | 2.21x | 2.46x | Skr-17.79 Million |
| 2025 | 7.92% | 1.42% | 2.34x | 2.38x | Skr-2.15 Million |
Industry Comparison
This section compares New Nordic Healthbrands AB (publ)'s net assets metrics with peer companies in the Packaged Foods industry.
Industry Context
- Industry: Packaged Foods
- Average net assets among peers: $2,170,833,736
- Average return on equity (ROE) among peers: -8.95%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| New Nordic Healthbrands AB (publ) (NNH) | Skr101.97 Million | -158.72% | 1.59x | $12.93 Million |
| AAK AB (AAK) | $17.17 Billion | 17.15% | 0.78x | $5.76 Billion |
| Humble Group AB (HUMBLE) | $8.54 Million | -120.88% | 0.37x | $268.39 Million |
| Lohilo Foods AB (LOHILO) | $23.41 Million | 1.05% | 1.43x | $8.47 Million |
| Midsona AB (publ) (MSON-A) | $877.00 Million | 7.53% | 0.77x | $725.13K |
| Midsona AB (publ) (MSON-B) | $751.00 Million | 8.39% | 0.60x | $180.24 Million |
| Scandi Standard publ AB (SCST) | $432.00 Million | -6.94% | 6.52x | $1.01 Billion |
| Swedencare publ AB (SECARE) | $98.27 Million | 23.73% | 0.20x | $377.57 Million |
| Skane mollan AB (SKMO) | $169.91 Million | 11.33% | 0.12x | $65.11 Million |
| Premium Snacks Nordic AB (SNX) | $4.38 Million | -21.88% | 1.84x | $45.52 Million |
About New Nordic Healthbrands AB (publ)
New Nordic Healthbrands AB (publ) manufactures and sells dietary supplements, herbal remedies, and related personal care products in the Nordic countries, rest of Europe, North America, and internationally. The company offers body care, dietary supplements, facial care, assortment, and natural magic trio products; hair volume series, dietary supplements, shampoo and conditioner, hair care, and ra… Read more